MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.690
-0.020 (-2.80%)
Nov 21, 2024, 10:58 AM EST - Market open
MiNK Therapeutics Employees
MiNK Therapeutics had 31 employees as of December 31, 2023. The number of employees decreased by 6 or -16.22% compared to the previous year.
Employees
31
Change (1Y)
-6
Growth (1Y)
-16.22%
Revenue / Employee
n/a
Profits / Employee
-$551,289
Market Cap
27.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | -6 | -16.22% |
| Dec 31, 2022 | 37 | 4 | 12.12% |
| Dec 31, 2021 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 775 |
| Pluri | 118 |
| ImmuCell | 79 |
| DURECT | 58 |
| Surrozen | 42 |
| GlycoMimetics | 35 |
| Daré Bioscience | 26 |
| Longeveron | 24 |
INKT News
- 7 days ago - MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 10 days ago - MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report - GlobeNewsWire
- 14 days ago - MiNK's iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024 - GlobeNewsWire
- 21 days ago - MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewsWire
- 6 weeks ago - MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors - GlobeNewsWire
- 6 weeks ago - MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024 - GlobeNewsWire
- 2 months ago - MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 3 months ago - MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript - Seeking Alpha